Growth Metrics

DBV Technologies (DBVT) Equity Average (2015 - 2026)

DBV Technologies (DBVT) reported Equity Average of $188.4 million for Q1 2026, up 1143.23% year-over-year from $15.2 million in Q1 2025, and up 69.95% on a QoQ basis from $110.8 million in Q4 2025.

DBV Technologies (DBVT) has 12 years of Equity Average data on file, last reported at $188.4 million in Q1 2026.

  • Quarterly Equity Average rose 1143.23% year-over-year to $188.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $188.4 million (up 1143.23% YoY) and the FY2025 annual result came in at $98.1 million, up 17.07% from the prior year.
  • Equity Average advanced to $188.4 million in Q1 2026 per DBVT's latest filing, from $110.8 million in the prior quarter.
  • Across five years, Equity Average topped out at $228.2 million in Q3 2022 and bottomed at $15.2 million in Q1 2025.
  • The 5-year median for Equity Average is $125.9 million (2024), against an average of $123.4 million.
  • The widest annual swing landed in 2025, when Equity Average slumped 87.97%; it then surged 1143.23% in 2026.
  • Tracing DBVT's Equity Average over 5 years: stood at $203.3 million in 2022, then slumped by 30.09% to $142.1 million in 2023, then slumped by 71.34% to $40.7 million in 2024, then jumped by 172.19% to $110.8 million in 2025, then surged by 69.95% to $188.4 million in 2026.
  • Per Business Quant, the three latest DBVT Equity Average figures stand at $188.4 million (Q1 2026), $110.8 million (Q4 2025), and $69.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Avg. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.76 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 21.35 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.01 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.34 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 932.28 Mn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn 188.35 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 188.35 Mn
Dec 31, 2025 110.83 Mn
Sep 30, 2025 69.54 Mn
Jun 30, 2025 44.56 Mn
Mar 31, 2025 15.15 Mn
Dec 31, 2024 40.72 Mn
Sep 30, 2024 66.56 Mn
Jun 30, 2024 95.37 Mn
Mar 31, 2024 125.92 Mn
Dec 31, 2023 142.09 Mn
Sep 30, 2023 154.12 Mn
Jun 30, 2023 171.67 Mn
Mar 31, 2023 186.77 Mn
Dec 31, 2022 203.25 Mn
Sep 30, 2022 228.23 Mn
Jun 30, 2022 163.24 Mn
Mar 31, 2022 90.67 Mn
Dec 31, 2021 108.08 Mn
Sep 30, 2021 129.96 Mn
Jun 30, 2021 156.10 Mn
Mar 31, 2021 187.33 Mn
Dec 31, 2020 219.30 Mn
Sep 30, 2020 242.42 Mn
Jun 30, 2020 275.70 Mn
Mar 31, 2020 244.78 Mn
Dec 31, 2019 142.71 Mn
Sep 30, 2019 113.11 Mn
Jun 30, 2019 134.57 Mn
Jun 30, 2018 198.77 Mn
Dec 31, 2017 181.87 Mn
Jun 30, 2017 236.49 Mn
Dec 31, 2016 295.21 Mn
Jun 30, 2016 340.62 Mn
Dec 31, 2015 234.89 Mn
Jun 30, 2015 130.52 Mn